Switch to: References

Add citations

You must login to add citations.
  1. Healthcare Priorities: The “Young” and the “Old”.Ben Davies - 2023 - Cambridge Quarterly of Healthcare Ethics 32 (2):174-185.
    Some philosophers and segments of the public think age is relevant to healthcare priority-setting. One argument for this is based in equity: “Old” patients have had either more of a relevant good than “young” patients or enough of that good and so have weaker claims to treatment. This article first notes that some discussions of age-based priority that focus in this way on old and young patients exhibit an ambiguity between two claims: that patients classified as old should have a (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Operative public values as a tool for healthcare decisions: the social value and clinical criteria of triage.Luis Cordeiro-Rodrigues - 2022 - Philosophy, Ethics, and Humanities in Medicine 17 (1):1-5.
    With the current pandemic, many scholars have contended that clinical criteria offer the best way to implement triage. Further, they dismiss the criteria of social value as a good one for triage. In this paper, I respond to refute this perspective. In particular, I present two sets of arguments. Firstly, I argue that the objections to the social value criteria they present apply to the clinical criteria they favor. Secondly, they exaggerate the negative aspects of the social value criteria, while (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Justifying a morally permissible breach of contract: kantian ethics, nozickian justice, and vaccine patents.Luís Cordeiro-Rodrigues - 2023 - Medicine, Health Care and Philosophy 26 (4):573-581.
    Although some have argued that COVID-19 vaccine patents are morally justified, a broader argument on the morality of breaching contracts is necessary. This article explores the ethics of breaching unfair contracts and argues that it is morally justified to breach contracts with pharmaceutical companies concerning vaccine patents. I offer two arguments to support this view. Firstly, contracts may be breachable in some situations. The ones I point out are that contracts can be broken when the costs of not violating vaccine (...)
    Download  
     
    Export citation  
     
    Bookmark